What Researchers Did
Researchers reported a case of a patient with multiple sclerosis who developed a rare eye side effect after hyperbaric oxygen therapy and subsequently reviewed existing literature on ocular toxicity of oxygen.
What They Found
They observed one patient with multiple sclerosis who developed an acute, bilateral, centro-caecal scotoma after hyperbaric oxygenation, which slowly resolved over several days. Their literature review indicated that hyperbaric oxygen can have ocular toxicity.
What This Means for Canadian Patients
Canadian patients with multiple sclerosis considering hyperbaric oxygen therapy should be aware of potential ocular side effects, such as vision changes. It is crucial to discuss all risks and benefits with their healthcare provider before undergoing such treatment.
Canadian Relevance
This study has no direct Canadian connection as it was not conducted in Canada, nor did it involve Canadian researchers or patients.
Study Limitations
A key limitation is that this study primarily reports on a single case and a literature review, which limits the generalizability of its findings to a broader patient population.